Actos Class Action Lawsuit
Class action lawsuits bring together plaintiffs with similar claims against a common defendant. For Actos lawsuit plaintiffs, a class action lawsuit generally seeks to hold drug maker Takeda liable for Actos bladder cancer and other serious side effects. As of early 2012, an Actos class action lawsuit was reportedly pending in the Eastern District of Louisiana; the same jurisdiction where Actos multidistrict legislation is pending.
FDA Issues Safety Warning for Actos Side Effects
The Food and Drug Administration (FDA) first approved Actos for use in 1999. By June 2011, the agency had determined that use of the diabetes medication for more than a year demonstrated a 40% increased risk of Actos bladder cancer. The agency’s public health communication read, “An increased risk of bladder cancer was observed among patients with the longest exposure to Actos… as well as in those exposed to the highest cumulative dose.” During 2011, France revealed similar conclusions and issued an Actos recall.
Actos class action filed
According to a national law firm, an Actos lawsuit class action was filed in the Eastern District of Louisiana on September 16, 2011. Class action lawsuits allow individuals to file against large companies, like Takeda, and to combine resources for a fighting chance. Any compensation collected as a result of a class action lawsuit is distributed to the individual plaintiffs according to predetermined criteria. The Actos class action was filed by two alleged sufferers of Actos bladder cancer, and holds Takeda and Eli Lily liable for the design, manufacture and distribution of a dangerous diabetes medication. The plaintiffs seek compensation and damages for their injuries.
Actos MDL and state consolidation
Due to a large number of Actos bladder cancer lawsuits, state and federal courts have begun to consider consolidation. On December 29, 2011, the U.S. Panel on Multidistrict Legislation ordered that all federal Actos bladder cancer lawsuits be evaluated for inclusion in federal multidistrict legislation, headquartered in Louisiana. At the time of the order, lawsuit were pending 8 federal districts, and more than 100 Actos bladder cancer lawsuits were being considered as tag-along legislation.
On the state level, California state judge Carl J. West ordered on January 4, 2012 that all California claims be consolidated into Los Angeles court. State consolidation, federal multidistrict legislation, and class action lawsuits, allow for a more streamlined legal process, since pretrial processes and other legal matters are handled jointly and one judge presides, thereby eliminating redundant testimony and conflicting rulings.